Start website main content

Ph.D. in Translational Medicine

  • Deadline for application submission 15.06.2017

The mission of the PhD Programme in Translational Medicine (henceforth named Programme) is to educate and train post-graduate students with diverse academic backgrounds and highly motivated to pursue a career in experimental biomedicine and/or clinical research. Special emphasis is put on the multidisciplinary approach in the area of cardiovascular sciences, with the ultimate aim of translating the results of laboratory and clinical research into novel and more effective diagnostic procedures and therapeutic strategies. A qualifying part of the curriculum is centered on basic and applied research towards development and validation of new drugs, nutraceuticals, therapeutic nanovectors and biomedical devices. On completion of the Programme, the PhD students is expected to have acquired a high level of training in experimental and/or clinical research methodologies, plus excellent skills in written and oral scientific communication.

The Programme offers 3 curricula:

1) Systems Physiology and Pathophysiology, Experimental and Clinical;

2) Molecular Physiology and Medicine;

3) Drug Discovery.

Each curriculum entails specific lines of research that the applicant ought to consider when he/she applies to the Programme.

The Tuscany Foundation "Gabriele Monasterio" – FTGM, in collaboration with the Institute of Life Sciences of the School, offers a scientific-clinical track as part of the Ph.D. Programme in Translational Medicine. Eligible candidates to the scientific-clinical track are first year Ph.D. students in Translational Medicine who hold a medical degree, the Italian “abilitazione all'esercizio della professione di medico chirurgo” and a Specialty diploma in one of the FTGM clinical areas, plus their research projects must be of FTGM interest. The Ph.D. Faculty Board, in agreement with the FTGM, determines the annual number of posts available for the scientific-clinical track. The Ph.D. students applying for the scientific-clinical track will be evaluated and selected by a Commission formed by four experts designated by the Ph.D. Faculty Board. The Ph.D. students admitted to the scientific-clinical track shall receive a scholarship supplement as compensation for their clinical activities. 


Positions Available

  • n. 8 positions with scholarship (1 position is reserved for citizens of NON-EU Countries)

of which:

2 positions funded by the Italian Institute of Technology Institute Genova

1 position funded by the Laboratory for Management and Health of the Scuola

The number of positions with scholarship may be increased if further funding becomes available

  • n. 2 Marie Skłodowska Curie additional scholarship positions are reserved for candidates who successfully participated in the FOIE GRAS ETN (Training Network for Early-Stage Researchers on Bioenergetic Remodeling in the Pathophysiology and Treatment of Non-Alcoholic Fatty Liver Disease) call (ESR 2 and ESR6) that will be published on EURAXESS and close on 28th January 2017.

Reserved for candidates submitting a research project on:

1) Krebs cycle remodeling in NAFLD; progetto n. 722619 — Foie Gras — H2020-MSCA-ITN-2016

2) GLP-1 as a key player in the gut-liver axis: role in NAFLD

How to Contact Us

To obtain more information please write to the following e-mail address:

info-phdlifesciences@santannapisa.it